Roger Maris Cancer Center

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma3 trials
• Lung cancer2 trials
• Childhood cancers1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• Mantle cell lymphoma1 trial
• Prostate cancer1 trial

Phase

• Phase 35 trials
• Phase 1/21 trial
• Phase 21 trial
• Phase 2/31 trial

Status

• Active, not recruiting4 trials
• Completed4 trials
• Terminated1 trial

Lead sponsor

• SWOG Cancer Research Network5 trials
• Celgene1 trial
• Eastern Cooperative Oncology Group1 trial
• ECOG-ACRIN Cancer Research Group1 trial
• Radiation Therapy Oncology Group1 trial

Running trials

• Active, not recruiting

  Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

  NCT02785952· Phase 3· SWOG Cancer Research Network· Source

• Active, not recruiting

  Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

  NCT01863550· Phase 3· ECOG-ACRIN Cancer Research Group· Source

• Active, not recruiting

  Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma

  NCT01415752· Phase 2· Eastern Cooperative Oncology Group· Source

• Active, not recruiting

  RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

  NCT00956007· Phase 3· Radiation Therapy Oncology Group· Source

Closed trials

• Completed

  S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

  NCT02438722· Phase 2/3· SWOG Cancer Research Network· Source

• Completed

  S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

  NCT01809691· Phase 3· SWOG Cancer Research Network· Source

• Completed

  S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

  NCT01668719· Phase 1/2· SWOG Cancer Research Network· Source

• Completed

  S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

  NCT01120249· Phase 3· SWOG Cancer Research Network· Source

• Terminated

  Connect® MM- The Multiple Myeloma Disease Registry

  NCT01081028· Celgene· Source